Repligen Corp (RGEN)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$157.93

Buy

$159.24

arrow-down$-1.995 (-1.24%)

Prices updated at 16 Dec 2025, 15:00 EST

Prices minimum 15 mins delay

Prices in USD

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

NASDAQ

0.26%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$160.99 - $157.42
	$182.52 - $102.97
	-
	9,041.42m
	8,029.00
	-
	47,093
	4.34
	799,336.54
	1.08
	56.09m
	US7599161095
	0.02
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.